Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • Lung inflammatory injury and tissue repair (Jul 2023)
    • Immune Environment in Glioblastoma (Feb 2023)
    • Korsmeyer Award 25th Anniversary Collection (Jan 2023)
    • Aging (Jul 2022)
    • Next-Generation Sequencing in Medicine (Jun 2022)
    • New Therapeutic Targets in Cardiovascular Diseases (Mar 2022)
    • Immunometabolism (Jan 2022)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Commentaries
    • Research letters
    • Letters to the editor
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • In-Press Preview
  • Commentaries
  • Research letters
  • Letters to the editor
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
The Gq/G11-mediated signaling pathway is critical for autocrine potentiation of insulin secretion in mice
Antonia Sassmann, … , Stefan Offermanns, Nina Wettschureck
Antonia Sassmann, … , Stefan Offermanns, Nina Wettschureck
Published May 3, 2010
Citation Information: J Clin Invest. 2010;120(6):2184-2193. https://doi.org/10.1172/JCI41541.
View: Text | PDF
Research Article Metabolism

The Gq/G11-mediated signaling pathway is critical for autocrine potentiation of insulin secretion in mice

  • Text
  • PDF
Abstract

A variety of neurotransmitters, gastrointestinal hormones, and metabolic signals are known to potentiate insulin secretion through GPCRs. We show here that β cell–specific inactivation of the genes encoding the G protein α-subunits Gαq and Gα11 resulted in impaired glucose tolerance and insulin secretion in mice. Interestingly, the defects observed in Gαq/Gα11-deficient β cells were not restricted to loss of muscarinic or metabolic potentiation of insulin release; the response to glucose per se was also diminished. Electrophysiological recordings revealed that glucose-induced depolarization of isolated β cells was impaired in the absence of Gαq/Gα11, and closure of KATP channels was inhibited. We provide evidence that this reduced excitability was due to a loss of β cell–autonomous potentiation of insulin secretion through factors cosecreted with insulin. We identified as autocrine mediators involved in this process extracellular nucleotides such as uridine diphosphate acting through the Gq/G11-coupled P2Y6 receptor and extracellular calcium acting through the calcium-sensing receptor. Thus, the Gq/G11-mediated signaling pathway potentiates insulin secretion in response to glucose by integrating systemic as well as autocrine/paracrine mediators.

Authors

Antonia Sassmann, Belinda Gier, Hermann-Josef Gröne, Gisela Drews, Stefan Offermanns, Nina Wettschureck

×

Figure 1

Characterization of β cell–specific Gαq/Gα11-deficient mice.

Options: View larger image (or click on image) Download as PowerPoint
Characterization of β cell–specific Gαq/Gα11-deficient mice.
   
(A) Wes...
(A) Western blots of extracts of whole pancreas or isolated islets probed with antibodies directed against Gαq/Gα11 or against α-tubulin as loading control. (B) OxoM-induced (50 μM) production of IPs in control (white) and Gαq/Gα11-deficient (black) β cells (n = 3 independent experiments). (C) Intracellular calcium mobilization in response to OxoM (50 μM) in Fura-2/AM–loaded control and mutant β cells. (D) Exemplary microphotographs of histological (original magnification, ×100) and immunohistochemical stainings (×200) as well as electron microscopic sections (EM, ×3,000) of pancreatic islets or individual β cells from control and β-Gαq/Gα11–deficient mice. (E and F) Quantification of the number (E) and size (F) of control and mutant islets (4 animals per group, 20 sections per animal). *P ≤ 0.05.

Copyright © 2023 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts